NCT02592707 2023-07-19Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETsIpsenPhase 1/2 Terminated40 enrolled 37 charts
NCT01088763 2014-11-05Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated129 enrolled